State MI
Clinical Trials in Michigan
Michigan is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Michigan and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 322 actively recruiting studies with Michigan sites out of 322 registered in total. The busiest research areas in Michigan are Advanced Solid Tumors, Small Cell Lung Cancer, Parkinson Disease. Leading sponsors running trials in the state include University of Michigan, National Cancer Institute (NCI), AstraZeneca. By stage, Michigan trials break down as Phase 1 (65), Phase 2 (105), Phase 3 (96), Phase 4 (10).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Michigan
Frequently Asked Questions — Clinical Trials in Michigan
How many clinical trials are currently recruiting in Michigan?
ClinicalMetric currently tracks 322 actively recruiting clinical trials with at least one location in Michigan. The total number of registered studies—including active but not currently enrolling trials—is 322. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Michigan?
Michigan hosts clinical trials across a broad range of medical conditions, including Advanced Solid Tumors, Small Cell Lung Cancer, Parkinson Disease, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Michigan serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Michigan?
To join a clinical trial in Michigan, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Michigan maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Michigan
NCT00567073 N/A
Recruiting
Pompe Pregnancy Sub-Registry
Condition
Glycogen Storage Disease Type II (GSD-II)
Enrollment
20 pts
Location
United States, Australia, Belgium
Sponsor
Genzyme, a Sanofi Company
NCT07723248 Phase 3
Recruiting
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Pati...
Condition
Metastatic Castration Resistant Prostate Cancer
Enrollment
600 pts
Location
United States, Puerto Rico
Sponsor
ORIC Pharmaceuticals
NCT07428538 Phase 3
Recruiting
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With ...
Condition
Hepatitis
Enrollment
350 pts
Location
United States
Sponsor
Bausch Health Americas, Inc.
NCT07221474 Phase 2
Recruiting
A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy i...
Condition
Squamous Non-small Cell Lung Cancer
Enrollment
180 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT02693535 Phase 2
Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That...
Condition
Lymphoma, Non-Hodgkin
Enrollment
4,200 pts
Location
United States, Puerto Rico
Sponsor
American Society of Clinical O
NCT06975865 Phase 3
Recruiting
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years Wit...
Condition
Sickle Cell Disease
Enrollment
192 pts
Location
United States, Belgium, Brazil
Sponsor
Sanofi
NCT06091865 Phase 3
Recruiting
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and Ho...
Condition
Diffuse Large B-cell Lymphoma (DLBCL)
Enrollment
904 pts
Location
United States, Australia, Austria
Sponsor
Regeneron Pharmaceuticals
NCT06959511 Phase 2
Recruiting
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
Condition
Neoadjuvant Treatment
Enrollment
45 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT07296484 Phase 2
Recruiting
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Condition
Type 2 Diabetes
Enrollment
1,500 pts
Location
United States
Sponsor
Sparrow Pharmaceuticals
NCT06925321 Phase 3
Recruiting
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult P...
Condition
Invasive Mold Infections
Enrollment
234 pts
Location
United States, Australia, Austria
Sponsor
Basilea Pharmaceutica
NCT06783309 Phase 1, Phase 2
Recruiting
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Wit...
Condition
Type 1 Diabetes Mellitus
Enrollment
72 pts
Location
United States
Sponsor
COUR Pharmaceutical Developmen
NCT04371900 N/A
Recruiting
Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1
Condition
Pregnancy
Enrollment
4,700 pts
Location
United States
Sponsor
University of Michigan
NCT05429632 Phase 3
Recruiting
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Al...
Condition
Adult Acute Myeloid Leukemia
Enrollment
366 pts
Location
United States, Argentina, Brazil
Sponsor
Priothera SAS
NCT07444814 Phase 1
Recruiting
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Dr...
Condition
Endometrial Cancer
Enrollment
226 pts
Location
United States
Sponsor
Whitehawk Therapeutics, Inc.
NCT06753916 Phase 2
Recruiting
ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty
Condition
Corneal Transplant Failure
Enrollment
96 pts
Location
United States
Sponsor
Massachusetts Eye and Ear Infi
NCT06298916 Phase 1, Phase 2
Recruiting
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Condition
Metastatic Sarcoma
Enrollment
26 pts
Location
United States
Sponsor
Lantheus Medical Imaging
NCT05419492 Phase 1, Phase 2
Recruiting
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Ch...
Condition
Dravet Syndrome
Enrollment
113 pts
Location
United States, Australia, United Kingdom
Sponsor
Encoded Therapeutics
NCT05267821 Phase 2, Phase 3
Recruiting
Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS
Condition
Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS)
Enrollment
500 pts
Location
United States
Sponsor
Nationwide Children's Hospital
NCT06568367 Phase 3
Recruiting
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shif...
Condition
Excessive Sleepiness
Enrollment
520 pts
Location
United States, Canada
Sponsor
Axsome Therapeutics, Inc.
NCT07720271 Phase 3
Recruiting
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People...
Condition
Overweight
Enrollment
950 pts
Location
United States
Sponsor
Novo Nordisk A/S
NCT07266428 Phase 1, Phase 2
Recruiting
A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advan...
Condition
Advanced Solid Tumors
Enrollment
170 pts
Location
United States, Australia, Brazil
Sponsor
Ottimo Pharma Limited
NCT06909565 Phase 4
Recruiting
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and...
Condition
Percutaneous Coronary Intervention
Enrollment
6,000 pts
Location
United States
Sponsor
Duke University
NCT01587300 N/A
Recruiting
Neuroblastoma Biology Study
Condition
Neuroblastoma
Enrollment
1,000 pts
Location
United States, Canada
Sponsor
New Approaches to Neuroblastom
NCT05919511 N/A
Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Condition
cGVHD
Enrollment
1,500 pts
Location
United States
Sponsor
Incyte Corporation
NCT07775248 Phase 4
Recruiting
Novel Extended-Release Bupivacaine Polymer for Sustained Pain Relief Following T...
Condition
Osteoarthritis (OA) of the Knee
Enrollment
150 pts
Location
United States
Sponsor
Henry Ford Health System
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology